(Q33862406)

29 July 2017

title

A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver (English)

1 reference

29 July 2017

H J Klasen

1

1 reference

29 July 2017

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

26

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

131-138

1 reference

TREATMENT OF LARGE HUMAN BURNS WITH 0.5 PER CENT SILVER NITRATE SOLUTION.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Organ Deposition of Silver Following Silver Nitrate Therapy of Burns

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

The treatment of extensive thermal burns with 0.5 per cent silver nitrate solution

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Results of the treatment of burns with silver nitrate

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Treatment of Severe Burns with Aqueous Silver Nitrate (0.5%)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

The successful control of burn wound sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Topical antisepsis studies in the burned rat

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Comparison of standard and chlorhexidine-derivative topical antibacterial agents on the infected burned rat wound

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Silver sulphadiazine-induced haemolytic anaemia in a glucose-6-phosphate dehydrogenase-deficient burn patient

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Mechanism of silver sulfadiazine action on burn wound infections

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Release and antimicrobial activity of silver sulphadiazine from different creams

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Electron-microscopic observation on silver deposition in burn wounds treated with silver sulphadiazine cream

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Acute leukopenia during topical burn therapy with silver sulfadiazine

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Acute Leukopenia Associated with Silver Sulfadiazine Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Current treatment recommendations for topical burn therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Topical and systemic antimicrobial agents in burns

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Topical and Systemic Antibacterial Agents in the Treatment of Burns

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Clinical Comparison of Maphenide and Silver Sulphadiazine

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Topical chemoprophylaxis for burns: Trials of creams containing silver sulphadiazine and trimethoprim

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Alternative forms of local treatment for burns

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Long-term experience with 1 per cent topical silver sulphadiazine cream in the management of burn wounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Silver sulphadiazine and the healing of partial thickness burns: a prospective clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

In vitro inactivation of silver sulphadiazine by the addition of cerium salts

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

The use of cerium nitrate-silver sulphadiazine as a topical burns dressing

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Use of topically applied silver sulphadiazine plus cerium nitrate in major burns

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Effect of cerium nitrate-silver sulphadiazine on deep dermal burns: a histological hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Control of burn wound infections by pefloxacin and its silver derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Silver-nylon: a new antimicrobial agent

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Weak direct current accelerates split-thickness graft healing on tangentially excised second-degree burns.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Optimized mesh expansion of composite skin grafts in rats treated with direct current.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

Regional and institutional variation in burn care

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900116-3

7 January 2021

10.1016/S0305-4179(99)00116-3

Identifiers

DOI

1 reference

29 July 2017

1 reference